With improved survival of patients with cystic fibrosis, a new management challenge is emerging—cystic fibrosis-related diabetes mellitus—but what aspects of the management of this disease are based on solid evidence? A new guideline takes steps towards providing the ultimate goal of a consistent and cogent management strategy.
